Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation-Reference-Cited by-同舟云学术

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

Published:2018-01-27 Issue:14 Volume:9 Page:11451-11464
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Retière Christelle¹,Willem Catherine¹²³,Guillaume Thierry²⁴³,Vié Henri¹²³,Gautreau-Rolland Laetitia²³,Scotet Emmanuel²³,Saulquin Xavier²³,Gagne Katia¹²⁵³,Béné Marie C.⁶³,Imbert Berthe-Marie⁷⁸³,Clemenceau Beatrice²³,Peterlin Pierre⁴,Garnier Alice⁴,Chevallier Patrice²⁴³

Affiliation:

1. Etablissement Français du Sang, Nantes, France

2. CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France

3. LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, F-44000, France

4. Hematology Department, CHU, Nantes, France

5. LabEx Transplantex, Université de Strasbourg, France

6. Hematology/Biology Department, CHU, Nantes, France

7. INSERM, Centre de Recherche en Transplantation et Immunologie, UMR1064, Université de Nantes, Nantes, France

8. Service de Virologie, CHU Nantes, Nantes, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Outcomes in Mismatched Unrelated Donor Allogeneic Transplantation: Post-Transplant Cyclophosphamide’s Dual Impact on Graft versus Host Disease Incidence and Overall Survival: Retrospective Analysis on Behalf of Polish Adult Leukemia Group;Journal of Clinical Medicine;2024-06-18

2. Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients;Transplant Immunology;2024-06

3. Shape of the art: TCR-repertoire after allogeneic hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-06

4. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

5. Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience;Hematology Reports;2024-04-17